FDA places clinical hold on Concert Pharma's hair loss drug
(Reuters) - Concert Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration imposed a clinical hold on a mid-stage trial testing the company's drug to treat alopecia areata, a type of hair loss.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Alopecia | Alopecia Areata | Food and Drug Administration (FDA) | Health | Pharmaceuticals